Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- DAS-MG, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT04226170
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
News
No news found